Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies

A Acosta, A Ciapponi, M Aaserud… - Cochrane Database …, 2014 - cochranelibrary.com
Background Pharmaceuticals are important interventions that could improve people's health.
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

M Aaserud, AT Dahlgren, JP Kösters… - The Cochrane …, 2006 - europepmc.org
Background Pharmaceuticals can be important for people's health. At the same time drugs
are major components of health care costs. Pharmaceutical pricing and purchasing policies …

[图书][B] WHO guideline on country pharmaceutical pricing policies

World Health Organization - 2020 - apps.who.int
Country Pharmaceutical Pricing Policies Page 1 ACCESS TO MEDICINES, VACCINES AND
PHARMACEUTICALS WHO Guideline on Country Pharmaceutical Pricing Policies WHO guideline …

Pharmaceutical policies: effects of financial incentives for prescribers

H Sturm, A Austvoll-Dahlgren, M Aaserud… - Cochrane Database …, 2007 - research.rug.nl
Background Pharmaceuticals, while central to medical therapy, pose a significant burden to
health care budgets. Therefore regulations to control prescribing costs and improve quality …

Determinants of drug prices: a systematic review of comparison studies

JMJ Daalen, A den Ambtman, M Van Houdenhoven… - BMJ open, 2021 - bmjopen.bmj.com
Objective In this systematic review on drug price comparison studies, we report on recent
determinants of drug prices in a national and international context to facilitate regulation of …

A systematic review of pharmaceutical pricing policies in developing countries

N Abdel Rida, MI Mohamed Ibrahim… - Journal of …, 2017 - academic.oup.com
Objective A systematic review was conducted to summarize government strategies aimed at
controlling pharmaceutical prices in developing countries and their effects on relevant …

Policy options for pharmaceutical pricing and purchasing: issues for low-and middle-income countries

TA Nguyen, R Knight, EE Roughead… - Health Policy and …, 2015 - academic.oup.com
Pharmaceutical expenditure is rising globally. Most high-income countries have exercised
pricing or purchasing strategies to address this pressure. Low-and middle-income countries …

Pharmaceutical policies: effects of financial incentives for prescribers

A Rashidian, AH Omidvari, Y Vali… - Cochrane Database …, 2015 - cochranelibrary.com
Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines

VL Luiza, LA Chaves, RM Silva… - Cochrane Database …, 2015 - cochranelibrary.com
Background Growing expenditures on prescription medicines represent a major challenge
to many health systems. Cap and co‐payment policies are intended as an incentive to deter …

Pharmaceutical policies: effects of restrictions on reimbursement

CJ Green, M Maclure, PM Fortin… - Cochrane Database …, 1996 - cochranelibrary.com
Background Public policy makers and benefit plan managers need to restrain rising
pharmaceutical drug costs while preserving access and optimizing health benefits …